Advertisement

Topics

AU SOMMAIRE DE BIOTECHFINANCES N° 775

01:01 EDT 3 Jul 2017 | Biotech-Finances

OSE IMMUNO : UNE COM’ EN DOUBLE AVEUGLE La biotech parisienne plonge dans le brouillard. Le recrutement des patients dans l’étude Atalante 1 – un essai clinique de phase III évaluant Tedopi, le candidat-médicament phare d’OSE, dans le cancer du poumon – a été suspendu sur recommandation des experts indépendants du comité de surveillance (IDMC). …

Cet article AU SOMMAIRE DE BIOTECHFINANCES N° 775 est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: AU SOMMAIRE DE BIOTECHFINANCES N° 775

NEXT ARTICLE

More From BioPortfolio on "AU SOMMAIRE DE BIOTECHFINANCES N° 775"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...